<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Di Minno A</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Impaired fasting glycemia (IFG) puts carriers at a significantly higher risk of developing type 2 diabetes and cardiovascular disease. Lifestyle changes, such as increased physical activity and a healthy diet rich in fiber and low in sugar, can often reverse prediabetes and significantly reduce the risk of progressing to type 2 diabetes metabolic disorders, especially diabetes (1).&lt;h4>Methods&lt;/h4>This randomized clinical trial aims to evaluate the efficacy and tolerability of a food supplement (FS) containing &lt;i>Citrus limon&lt;/i> L. Osbeck and &lt;i>Vitis vinifera&lt;/i> L. extracts, hesperidin from &lt;i>Citrus sinensis&lt;/i> L. Osbeck, and chromium, in individuals with impaired fasting blood glucose , with the final goal of investigating whether the use of a combination of ingre</pubmed_abstract><journal>Frontiers in nutrition</journal><pagination>1671102</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12558782</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of a food supplement containing &amp;lt;i&amp;gt;Citrus limon&amp;lt;/i&amp;gt; L. Osbeck and &amp;lt;i&amp;gt;Vitis vinifera&amp;lt;/i&amp;gt; L. extracts, hesperidin and chromium in combination with an isocaloric diet on glucose and lipid metabolism in subjects with impaired fasting blood glucose: a single-center, controlled, randomized, parallel-arm, double-blind clinical trial.</pubmed_title><pmcid>PMC12558782</pmcid><pubmed_authors>Borromeo L</pubmed_authors><pubmed_authors>Santonastaso S</pubmed_authors><pubmed_authors>Piccinocchi R</pubmed_authors><pubmed_authors>El-Seedi H</pubmed_authors><pubmed_authors>Greco A</pubmed_authors><pubmed_authors>Xiao X</pubmed_authors><pubmed_authors>Sacchi R</pubmed_authors><pubmed_authors>De Lellis LF</pubmed_authors><pubmed_authors>Baldi A</pubmed_authors><pubmed_authors>Buccato DG</pubmed_authors><pubmed_authors>Cerqua A</pubmed_authors><pubmed_authors>Daglia M</pubmed_authors><pubmed_authors>Morone MV</pubmed_authors><pubmed_authors>Ullah H</pubmed_authors><pubmed_authors>Larsen DS</pubmed_authors><pubmed_authors>Riccioni CV</pubmed_authors><pubmed_authors>Piccinocchi G</pubmed_authors><pubmed_authors>Di Minno A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of a food supplement containing &amp;lt;i&amp;gt;Citrus limon&amp;lt;/i&amp;gt; L. Osbeck and &amp;lt;i&amp;gt;Vitis vinifera&amp;lt;/i&amp;gt; L. extracts, hesperidin and chromium in combination with an isocaloric diet on glucose and lipid metabolism in subjects with impaired fasting blood glucose: a single-center, controlled, randomized, parallel-arm, double-blind clinical trial.</name><description>&lt;h4>Introduction&lt;/h4>Impaired fasting glycemia (IFG) puts carriers at a significantly higher risk of developing type 2 diabetes and cardiovascular disease. Lifestyle changes, such as increased physical activity and a healthy diet rich in fiber and low in sugar, can often reverse prediabetes and significantly reduce the risk of progressing to type 2 diabetes metabolic disorders, especially diabetes (1).&lt;h4>Methods&lt;/h4>This randomized clinical trial aims to evaluate the efficacy and tolerability of a food supplement (FS) containing &lt;i>Citrus limon&lt;/i> L. Osbeck and &lt;i>Vitis vinifera&lt;/i> L. extracts, hesperidin from &lt;i>Citrus sinensis&lt;/i> L. Osbeck, and chromium, in individuals with impaired fasting blood glucose , with the final goal of investigating whether the use of a combination of ingre</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-15T03:17:47.341Z</modification><creation>2026-05-15T03:11:58.328Z</creation></dates><accession>S-EPMC12558782</accession><cross_references><pubmed>41164360</pubmed><doi>10.3389/fnut.2025.1671102</doi></cross_references></HashMap>